Journal
NEUROCHEMICAL RESEARCH
Volume 37, Issue 4, Pages 722-731Publisher
SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s11064-011-0664-2
Keywords
Lipopolysaccharide; Schwann cell; Tumor necrosis factor-alpha; NF-kappa B
Categories
Funding
- National Basic Research Program of China (973 Program) [2011CB910604, 2012BC822104]
- National Natural Science Foundation of China [31070723, 81070275, 81172879, 31100112]
- Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)
- college and university Natural Scientific Research Programme of Jiangsu Province [11KJA310002]
- Scientific Research Programme of Nantong [BK2011019]
- Natural Science Foundation of NanTong University [08Z044]
Ask authors/readers for more resources
Lipopolysaccharide (LPS) is recognized by Toll-like receptor 4 and activates mitogen-activated protein kinase, which leads to the induction of proinflammatory cytokine gene expression. In vivo, Schwann cells (SCs) at the site of injury may also produce tumor necrosis factor-alpha (TNF-alpha). However, the precise mechanism that regulates TNF-alpha synthesis is still not clear. The nuclear transcription factor-kappa B(NF-kappa B) is an important transcription factor which is involved in the regulation of host immune responses. In the present study, we found that LPS possessed a comparable specific activity for activation of NF-kappa B-dependent gene expression in SCs. We also observed I kappa B-alpha/I kappa B-beta degradation and the nuclear translocation of P65 due to LPS treatments. LPS-elicited TNF-alpha production in SCs was also drastically suppressed by SN50 (NF-kappa B inhibitor).
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available